Cordis, a Cardinal Health company, will begin marketing the technologically advanced Railway Sheathless Access System in India this year. Cordis’ Railway System is indicated for use in radial artery procedures requiring percutaneous introduction of intravascular devices.
A percutaneous procedure is a method that allows doctors to insert a medical device into a patient’s blood vessel by using a needle, a guidewire, an introducer sheath and a catheter. The catheter is used to deliver medication or implant a stent into the blood vessel.
The innovative Railway System is designed to enable direct access to the radial artery in the wrist with a guiding catheter without the use of an introducer sheath. This reduces the size of the arterial puncture site by up to 2F compared to a conventional sheath system. The Railway System will be available in India later this year.
“In our experience the Cordis Railway sheathless access system minimises the radial artery trauma and disruption, by reducing artery puncture size up to 2F (33 per cent) while allowing larger bore guide catheter use during transradial coronary procedures. In our study the Railway system reduced the incidence of spasms, radial trauma and improved the transradial access success rate for complex coronary procedures. This resulted in reduced vascular complications, leading to early ambulation and discharge from the hospital,” said Dr Kintur Sanghvi, Associate Medical Director of Interventional Cardiology and Endovascular Medicine at Deborah Heart & Lung Center in Browns Mills, New Jersey, the inventor of the Railway System.
